Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-26

FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for the generic drug Glipizide from Apotex Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)